Worms P, Kan J P, Wermuth C G, Biziere K
Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):246-52. doi: 10.1007/BF00508778.
The behavioural effects of CM 30366, an aminopyridazine derivative, on dopamine-mediated neurotransmissions, have been studied in mice and rats. CM 30366 induced stereotyped behaviour and antagonized haloperidol-induced catalepsy in rats, after parenteral and oral administration. In 6-hydroxy dopamine (6-OHDA)-lesioned mice, CM 30366 induced contralateral rotations and, when injected before 6-OHDA, protected mice against its neurotoxicity. CM 30366 also provoked contralateral rotations when injected directly into the mouse right striatum. After parenteral injection, CM 30366 slightly increased motility in mice, at least at low doses. The stereotypies and rotations (after intrastriatal injection) induced by CM 30366 were antagonized by haloperidol, alpha-methyl-p-tyrosine and reserpine. The effects of CM 30366 were compared to those of direct and indirect dopamine-like drugs. Bromocriptine induced a behavioural profile, which in most aspects, was qualitatively and quantitatively similar to that of CM 30366. Apomorphine was found slightly more potent than CM 30366, but in contrast to the latter, apomorphine-induced stereotypies were insensitive to alpha-methyl-p-tyrosine or reserpine. (+)-Amphetamine and nomifensine were less potent than CM 30366, and unlike CM 30366, induced ipsilateral rotations in 6-OHDA-lesioned mice. These results indicate that CM 30366 is a potent atypical dopamine-like drug of potential therapeutic usefulness.
已在小鼠和大鼠中研究了氨基哒嗪衍生物CM 30366对多巴胺介导的神经传递的行为影响。经肠胃外和口服给药后,CM 30366在大鼠中诱导刻板行为并拮抗氟哌啶醇诱导的僵住症。在6-羟基多巴胺(6-OHDA)损伤的小鼠中,CM 30366诱导对侧旋转,并且在6-OHDA之前注射时,可保护小鼠免受其神经毒性。直接注射到小鼠右纹状体中时,CM 30366也会引发对侧旋转。肠胃外注射后,CM 30366至少在低剂量时会略微增加小鼠的运动能力。CM 30366诱导的刻板行为和旋转(纹状体内注射后)被氟哌啶醇、α-甲基-对-酪氨酸和利血平拮抗。将CM 30366的作用与直接和间接多巴胺样药物的作用进行了比较。溴隐亭诱导的行为特征在大多数方面在定性和定量上与CM 30366相似。发现阿扑吗啡比CM 30366稍有效,但与后者不同的是,阿扑吗啡诱导的刻板行为对α-甲基-对-酪氨酸或利血平不敏感。(+)-苯丙胺和诺米芬辛比CM 30366效力低,并且与CM 30366不同,在6-OHDA损伤的小鼠中诱导同侧旋转。这些结果表明,CM 30366是一种具有潜在治疗用途的强效非典型多巴胺样药物。